23 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications ... #overview #management
Daptomycin  - Antibiotics Class Overview

Mechanism: Lipopeptide antibiotic – forms transmembrane channels and depolarizes cells.
Antibiotics Class Overview ... and depolarizes cells ... skin/soft tissue infections ... cidal nature) #Pharmacology ... Antibiotics #Review #Overview
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... CD4 count <100 cells ... Treating Acute Infection ... opportunistic #infections ... #HIVAIDS #pharmacology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
commonly used medications ... to treat Type 2 Diabetes ... mistaken these medications ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Treating Isospora belli ... Infection in HIV-AIDS ... Treating Isospora belli ... Infection General ... #HIVAIDS #pharmacology
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Aplastic Anemia - Overview ... Neutropenia - recurrent infections ... - Antithyroid medications ... Idiopathic • Infections ... number of CD34+ cells
GLP-1 Medications: Ozempic vs. Trulicib (semaglutide vs. dulaglutide) 

From my experience, Ozempic and Trulicity are the
GLP-1 Medications ... are weekly dosed injections ... Hopefully this overview ... #dulaglutide #Pharmacology ... #Diabetes #Comparison
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
-6 activates T cells ... respiratory tract infection ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
CD4 count <200 cells ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
CD4 count <100 cells ... opportunistic #infections ... #HIVAIDS #management ... #pharmacology # ... pharmacology